Recombinant multi-species ZBTB7B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ZBTB7B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a zinc finger-containing transcription factor that acts as a key regulator of lineage commitment of immature T-cell precursors. It is necessary and sufficient for commitment of CD4 lineage, while its absence causes CD8 commitment. It also functions as a transcriptional repressor of type I collagen genes. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2012]
The Alternative Names of target: CKROX,Krueppel-related zinc finger protein cKrox (hcKrox),T-helper-inducing POZ/Krueppel-like factor,THPOK,Thpok,ZBTB15,ZBTB7B,ZFP-67,ZFP67,ZNF857B,Zbtb7b,Zfp67,Zinc finger and BTB domain-containing protein 15,Zinc finger and BTB domain-containing protein 7B,Zinc finger protein 67 homolog (Zfp-67),Zinc finger protein 857B,Zinc finger protein Th-POK,c-KROX,c-Krox,hcKROX,vGAF

Target products collectionGo to ZBTB7B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP9256-Ag-1/ GM-Tg-hg-IP9256-Ag-2 Human ZBTB7B protein Human
GM-Tg-rg-IP9256-Ag-1/ GM-Tg-rg-IP9256-Ag-2 Rat ZBTB7B protein Rat
GM-Tg-mg-IP9256-Ag-1/ GM-Tg-mg-IP9256-Ag-2 Mouse ZBTB7B protein Mouse
GM-Tg-cynog-IP9256-Ag-1/ GM-Tg-cynog-IP9256-Ag-2 Cynomolgus/Rhesus macaque ZBTB7B protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP9256-Ag-1/ GM-Tg-felg-IP9256-Ag-2 Feline ZBTB7B protein Feline
GM-Tg-cang-IP9256-Ag-1/ GM-Tg-cang-IP9256-Ag-2 Canine ZBTB7B protein Canine
GM-Tg-bovg-IP9256-Ag-1/ GM-Tg-bovg-IP9256-Ag-2 Bovine ZBTB7B protein Bovine
GM-Tg-equg-IP9256-Ag-1/ GM-Tg-equg-IP9256-Ag-2 Equine ZBTB7B protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP9256-Ag-1/ GM-Tg-hg-IP9256-Ag-2; GM-Tg-rg-IP9256-Ag-1/ GM-Tg-rg-IP9256-Ag-2;
GM-Tg-mg-IP9256-Ag-1/ GM-Tg-mg-IP9256-Ag-2; GM-Tg-cynog-IP9256-Ag-1/ GM-Tg-cynog-IP9256-Ag-2;
GM-Tg-felg-IP9256-Ag-1/ GM-Tg-felg-IP9256-Ag-2; GM-Tg-cang-IP9256-Ag-1/ GM-Tg-cang-IP9256-Ag-2;
GM-Tg-bovg-IP9256-Ag-1/ GM-Tg-bovg-IP9256-Ag-2; GM-Tg-equg-IP9256-Ag-1/ GM-Tg-equg-IP9256-Ag-2
Products Name ZBTB7B protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ZBTB7B
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ZBTB7B protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.